Posted on 21/01/2010 in Pharmaceutical Company Product News Sanofi Pasteur revealed this week that two of its vaccines have made it on to Time magazine's list of the ten most prolific medical breakthroughs ever.
The firm's HIV vaccine came in second place and the publication highlighted that trials into its effectiveness yielded "reasonable" results, with an infection prevention rate of 31 per cent.
However, the implications of this are what is important, it furthered, as "given that no other inoculation has shown any effect against the AIDS virus, it was reason to celebrate - cautiously".
In fourth place was Sanofi Pasteur's H1N1 vaccine, for which demand outstripped supply when it was launched last year.
The magazine highlighted that, in some areas, "there was not enough vaccine even to cover members of priority groups", as people prepared to do all they could to protect themselves against the flu virus.
Earlier this month, Sanofi Pasteur signed a contract with the privately held biotech company KaloBios Pharmaceuticals, which will see them cooperate to develop an antibody to treat and prevent pseudomonas aeruginosa infections.Other news stories from 21/01/2010
Read more in the Zenopa News Archive
How this news is generated
|
